SANFER

Serial Number 88843993
Registration 6292319
700

Registration Progress

Application Filed
Mar 23, 2020
Under Examination
Approved for Publication
Dec 29, 2020
Published for Opposition
Dec 29, 2020
Registered
Mar 16, 2021

Trademark Image

SANFER

Basic Information

Serial Number
88843993
Registration Number
6292319
Filing Date
March 23, 2020
Registration Date
March 16, 2021
Published for Opposition
December 29, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 16, 2021
Registration
Registered
Classes
005

Rights Holder

Laboratorios Sanfer, S.A. de C.V.

03
Address
#314-1A, Blvd. Adolfo Lopez Mateos
Col. Tlacopac 01049
MX

Ownership History

Laboratorios Sanfer, S.A. de C.V.

Original Applicant
03
Col. Tlacopac MX

Laboratorios Sanfer, S.A. de C.V.

Owner at Publication
03
Col. Tlacopac MX

Laboratorios Sanfer, S.A. de C.V.

Original Registrant
03
Col. Tlacopac MX

Legal Representation

Attorney
John M. Murphy

USPTO Deadlines

Next Deadline
588 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-16)
Due Date
March 16, 2027
Grace Period Ends
September 16, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Jan 15, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 15, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 15, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 15, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 15, 2024 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jan 15, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 12, 2023 WOAG I WITHDRAWAL OF ATTORNEY GRANTED Loading...
Jul 12, 2023 WOAR I TEAS WITHDRAWAL OF ATTORNEY RECEIVED Loading...
Mar 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 29, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 29, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 9, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 24, 2020 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Nov 10, 2020 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Oct 30, 2020 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Oct 27, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 26, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 26, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 26, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 15, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 23, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 22, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 18, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 18, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 18, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 15, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 26, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 26, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines and pharmaceutical preparations, namely, pharmaceutical and medicinal products for ophthalmic use, antipyretics, analgesics, anesthetics, antiallergic medicines, antihistamines, antidotes, arsenic detoxification agents for medical purposes, benzol detoxification agents for medical purposes, chlorine detoxification agents for medical purposes, opium alkaloid preparations, smoking cessation preparations, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, anti-cancer preparations, anti-arthritic compositions and preparations, antiphlogistic analgesics, anti-rheumatic, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertensions, antitussives, expectorants, inhalant anesthetics, cardiovascular treatment preparations, analeptics, pharmaceutical preparations for treating hypertension, antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of heart rhythm disorders, antihypertensives, vasodilators, chemotherapeutics, antibiotic preparations, antifungal preparations, anti-tuberculous preparations, anti-leprotic agents, anti-protozoa preparations, medicinal preparations used in the treatment of malaria, antivirals, antiparasitic preparations, dermatological pharmaceutical products, antiparasitic preparations, dermatologics, radio-isotope markers for therapeutic or diagnostic use, dietary supplements, disinfectants, diuretics and anti-diuretics, antianemia drugs, anticoagulants, preparations for transfusions, enzymes for medical purposes, enzyme inhibitors, nutraceuticals for use as a dietary supplement for liver support, medicines for treatment of gastrointestinal diseases, antacids, diarrhea medication, anthelmintics, emetics, anti-emetic pharmaceutical preparations, medicated mouthwash for treating ulcers, antiflatulents, digestives for pharmaceutical purposes, medicines for use in indigestion, anti-inflammatories, laxatives, antiseptics, pharmaceutical preparations for the treatment and prevention of women's disorders and diseases, specifically, pharmaceutical preparations for assisted reproductive therapy, pharmaceutical preparations for the prevention and treatment of luteal phase defects and the prevention of miscarriages, immunosuppressants, dietary and nutritional supplements for anabolic use, antidiabetic preparations, dietary and nutritional supplements used for weight loss, pharmaceutical preparations for the treatment of anorexia; pharmaceutical agents affecting metabolism, pharmaceutical preparations for the treatment of Parkinson's disease, hypnotic sedatives, neuroleptics, tranquilizers, antidepressants, anti-psychotic pharmaceutical preparations, analeptics, neuropathical agents and other neurotropic agents, hormones for medical purposes, poly-opotherapeutic curative preparations for postponing manifestations of aging, estrogen preparations, progestogens, contraceptive preparations, androgen preparations, anti-hormone drugs, otorhinolaryngological preparations, otorhinolaryngological serums, vaccines, antispasmodics, vitamins, dietary and nutritional supplements containing coenzyme q10, multivitamin preparations, pharmaceutical preparations for sublingual use for treatment of heart problems; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Additional Information

Design Mark
The mark consists of the word "SANFER" in stylized form.

Classification

International Classes
005